Karyopharm begins dosing in late-stage study of selinexor combo therapy for multiple myeloma
Karyopharm Therapeutics (KPTI) and the European Myeloma Network ((EMN)), a collaboration of centers for multiple myeloma in Europe and Australia, said the first patient was dosed in…
Karyopharm begins dosing in late-stage study of selinexor combo therapy for multiple myeloma
Karyopharm Therapeutics (KPTI) and the European Myeloma Network ((EMN)), a collaboration of centers for multiple myeloma in Europe and Australia, said the first patient was dosed in…